Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
In HFmrEF or HFrEF, digitalis glycosides reduce a composite of CV death or worsening HF event vs. placebo at a median 36 to 37 mo.
Journal: Annals of internal medicine
Published: August 31, 2026
Place of Death Among Patients Dying of Kidney Failure: Insights From the CDC Wonder Database.
Journal: Kidney medicine
Published: July 30, 2026
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.
Journal: JAMA
Published: July 29, 2026
Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations.
Journal: Journal of clinical lipidology
Published: May 26, 2026
Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.
Journal: Current atherosclerosis reports
Published: May 22, 2026
A quarter-century mortality analysis of concomitant infective endocarditis and stroke in the United States - A nationwide CDC WONDER study.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: May 14, 2026
Stepping it Up on Temporary Mechanical Circulatory Support - Mobilization and Prehabilitation of patients in ICU.
Journal: Journal of cardiac failure
Published: March 25, 2026
A nationwide retrospective analysis of trends in palliative care consultation and do-not-resuscitate status in heart failure hospitalizations.
Journal: Palliative medicine
Published: February 21, 2026
Potassium Levels and Risk of Ventricular Arrhythmias.
Journal: The New England journal of medicine
Published: February 11, 2026
U.S. cardiovascular mortality before and during COVID-19: CDC WONDER vs GBD comparison.
Journal: American journal of epidemiology
Published: January 24, 2026
Multimodal Detection of Subclinical Cardiovascular Disease in Chronic Kidney Disease.
Journal: Cardiorenal medicine
Published: December 29, 2025
Liver fibrosis biomarkers as a prognostic tool beyond the defining components in cardiovascular-kidney-metabolic syndrome.
Journal: American journal of preventive cardiology
Published: December 05, 2025
Last Updated: 09/26/2026